Biomarkers Market size to grow by USD 56,267.85 million from 2022 to 2027; 38% of global market growth to originate from North America - Technavio

NEW YORK, June 22, 2023 /PRNewswire/ -- The biomarkers market size is expected to grow by USD 56,267.85 million from 2022 to 2027, progressing at a CAGR of 13.05% as per the latest Technavio market research report. North America is estimated to account for 38% of the market's overall growth. The US accounted for the largest market share in the region. There is an increase in the number of molecular biomarker information over the past decade. Furthermore, the demand for efficient and precise biomarkers has increased due to the rising prevalence of chronic diseases in the US. Hence, such factors boost regional growth during the forecast period. For more insights on the market share of various regions- Download sample report in MINUTES

Biomarkers Market: Market Dynamics

Biomarkers Market: Increasing prevalence of heart diseases to drive growth

• The increasing prevalence of heart diseases drives the growth of the biomarkers market during the forecast period.
• The rise in the use of biomarkers for patients with heart disease has grown over the past few years.
• Furthermore, smoking, high prevalence of cardiac arrhythmias, atherosclerosis, diabetes, and high cholesterol are other factors that indirectly contribute to the prevalence of heart disease.
• Also, the prevalence of CVDs is increasing owing to the growth of risk factors, such as diabetes, hypertension, smoking, and obesity.
• Hence, such factors boost the market growth during the forecast period.

Biomarkers Market: Growing Number of Research and Development Programs and New Product Launches 

• The growing number of research and development programs and new product launches fuel the market growth during the forecast period. 
• For instance, according to an article from the British Journal of Cancer on October 3, 2022, using the BC-116 biomarker panel as a test to detect primary bladder cancer is beneficial.
• Similarly, in October 2021, DarwinHealth and Prelude Therapeutics started to work together to create novel biomarkers for numerous oncology candidates.
• Furthermore, the revenue share of the cardiovascular diseases segment was the second largest in 2022.
• Hence, the growing number of R&D programs and new product launches are expected to boost the growth of the global biomarkers market during the forecast period.

To know about more drivers, trends along with challenges - Download a sample now!

Some of the key Biomarkers Market Players:

The biomarkers market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Abbott Laboratories, Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., BG Medicine Inc., Bio Techne Corp., CENTOGENE NV, Charles River Laboratories International Inc., DiaSorin Spa, EKF Diagnostics Holdings Plc, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., General Electric Co., Merck KGaA, Meso Scale Diagnostics LLC, Nexus Dx Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, and Thermo Fisher Scientific Inc.

Why Buy?

• Add credibility to strategy
• Analyzes competitor's offerings 
• Get a holistic view of the market

Grow your profit margin with Technavio- Buy the Report

Biomarkers Market: Segmentation Analysis

This biomarkers market report extensively covers market segmentation by type (safety, efficacy, and validation), application (drug discovery and development, diagnostics, and personalized medicine), and geography (North America, Europe, Asia, and Rest of World (ROW)).

• The market share growth by the safety segment will be significant for market growth during the forecast period. To identify and control any potential toxicity of drugs, regular monitoring of biomarkers is necessary. Furthermore, effects on biomarkers can sometimes lead to rare but potentially harmful toxicity. Moreover, biomarkers can be used to identify patients for whom specific therapies should not be started due to significant safety risks. Hence, the various benefits of safety biomarkers are expected to increase their use, which will further drive the growth of the safety biomarkers segment in the global biomarkers market during the forecast period.

Gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Related Reports:

The Global Cardiac Biomarkers Market size is estimated to grow by USD 7,880.86 million between 2022 and 2027 accelerating at a CAGR of 12.6%. This cardiac biomarkers market research report extensively covers market segmentation by technology (conventional laboratory testing and POC testing), product (troponin, BNP and NT-proBNP, CK-MB, myoglobin, and others), end-user (hospitals, clinics, and diagnostic laboratories), and geography (North America, Europe, Asia, and Rest Of World (ROW)). The rising number of M and A and new product launches are notably driving the cardiac biomarkers market growth.

The renal biomarkers market size is expected to increase by USD 507.23 million from 2021 to 2026, at a CAGR of 7.40%. This renal biomarkers market research report extensively covers renal biomarkers market segmentation by end-user (hospitals, clinics and diagnostic laboratories, and research laboratories) and geography (North America, Europe, Asia, and ROW). The rising prevalence of chronic kidney diseases is one of the key drivers supporting renal biomarkers market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022 

• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global biomarkers market 2017 - 2021
• Exhibit 18: Historic Market Size – Data Table on global biomarkers market 2017 - 2021 ($ million)

• 4.2 Type Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ million)

• 4.3 Application Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size – Application Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

• 6.1 Market segments 
• Exhibit 30: Chart on Type - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Type - Market share 2022-2027 (%)

• 6.2 Comparison by Type 
• Exhibit 32: Chart on Comparison by Type
• Exhibit 33: Data Table on Comparison by Type

• 6.3 Safety - Market size and forecast 2022-2027
• Exhibit 34: Chart on Safety - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Safety - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Safety - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Safety - Year-over-year growth 2022-2027 (%)

• 6.4 Efficacy - Market size and forecast 2022-2027
• Exhibit 38: Chart on Efficacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Efficacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Efficacy - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Efficacy - Year-over-year growth 2022-2027 (%)

• 6.5 Validation - Market size and forecast 2022-2027
• Exhibit 42: Chart on Validation - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Validation - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Validation - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Validation - Year-over-year growth 2022-2027 (%)

• 6.6 Market opportunity by Type 
• Exhibit 46: Market opportunity by Type ($ million)
• Exhibit 47: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Application

• 7.1 Market segments 
• Exhibit 48: Chart on Application - Market share 2022-2027 (%)
• Exhibit 49: Data Table on Application - Market share 2022-2027 (%)

• 7.2 Comparison by Application 
• Exhibit 50: Chart on Comparison by Application
• Exhibit 51: Data Table on Comparison by Application

• 7.3 Drug discovery and development - Market size and forecast 2022-2027 
• Exhibit 52: Chart on Drug discovery and development - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Drug discovery and development - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Drug discovery and development - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Drug discovery and development - Year-over-year growth 2022-2027 (%)

• 7.4 Diagnostics - Market size and forecast 2022-2027
• Exhibit 56: Chart on Diagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Diagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Diagnostics - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Diagnostics - Year-over-year growth 2022-2027 (%)

• 7.5 Personalized medicine - Market size and forecast 2022-2027 
• Exhibit 60: Chart on Personalized medicine - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Personalized medicine - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Personalized medicine - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Personalized medicine - Year-over-year growth 2022-2027 (%)

• 7.6 Market opportunity by Application 
• Exhibit 64: Market opportunity by Application ($ million)
• Exhibit 65: Data Table on Market opportunity by Application ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 67: Chart on Market share by geography 2022-2027 (%)
• Exhibit 68: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 69: Chart on Geographic comparison
• Exhibit 70: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027
• Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 UK - Market size and forecast 2022-2027
• Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.9 Germany - Market size and forecast 2022-2027
• Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.10 China - Market size and forecast 2022-2027
• Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.11 Japan - Market size and forecast 2022-2027
• Exhibit 103: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on Japan - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 107: Market opportunity by geography ($ million)
• Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers 

• 10.2 Market challenges 

• 10.3 Impact of drivers and challenges 
• Exhibit 109: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends 

11 Vendor Landscape

• 11.1 Overview 

• 11.2 Vendor landscape 
• Exhibit 110: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 111: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 112: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 113: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 114: Matrix on vendor position and classification

• 12.3 Abbott Laboratories 
• Exhibit 115: Abbott Laboratories - Overview
• Exhibit 116: Abbott Laboratories - Business segments
• Exhibit 117: Abbott Laboratories - Key news
• Exhibit 118: Abbott Laboratories - Key offerings
• Exhibit 119: Abbott Laboratories - Segment focus

• 12.4 Agilent Technologies Inc. 
• Exhibit 120: Agilent Technologies Inc. - Overview
• Exhibit 121: Agilent Technologies Inc. - Business segments
• Exhibit 122: Agilent Technologies Inc. - Key offerings
• Exhibit 123: Agilent Technologies Inc. - Segment focus

• 12.5 Becton Dickinson and Co. 
• Exhibit 124: Becton Dickinson and Co. - Overview
• Exhibit 125: Becton Dickinson and Co. - Business segments
• Exhibit 126: Becton Dickinson and Co. - Key news
• Exhibit 127: Becton Dickinson and Co. - Key offerings
• Exhibit 128: Becton Dickinson and Co. - Segment focus

• 12.6 BG Medicine Inc. 
• Exhibit 129: BG Medicine Inc. - Overview
• Exhibit 130: BG Medicine Inc. - Product / Service
• Exhibit 131: BG Medicine Inc. - Key offerings

• 12.7 Bio Techne Corp. 
• Exhibit 132: Bio Techne Corp. - Overview
• Exhibit 133: Bio Techne Corp. - Business segments
• Exhibit 134: Bio Techne Corp. - Key news
• Exhibit 135: Bio Techne Corp. - Key offerings
• Exhibit 136: Bio Techne Corp. - Segment focus

• 12.8 CENTOGENE NV 
• Exhibit 137: CENTOGENE NV - Overview
• Exhibit 138: CENTOGENE NV - Product / Service
• Exhibit 139: CENTOGENE NV - Key offerings

• 12.9 Charles River Laboratories International Inc.
• Exhibit 140: Charles River Laboratories International Inc. - Overview
• Exhibit 141: Charles River Laboratories International Inc. - Business segments
• Exhibit 142: Charles River Laboratories International Inc. - Key news
• Exhibit 143: Charles River Laboratories International Inc. - Key offerings
• Exhibit 144: Charles River Laboratories International Inc. - Segment focus

• 12.10 EKF Diagnostics Holdings Plc 
• Exhibit 145: EKF Diagnostics Holdings Plc - Overview
• Exhibit 146: EKF Diagnostics Holdings Plc - Business segments
• Exhibit 147: EKF Diagnostics Holdings Plc - Key offerings
• Exhibit 148: EKF Diagnostics Holdings Plc - Segment focus

• 12.11 Eurofins Scientific SE 
• Exhibit 149: Eurofins Scientific SE - Overview
• Exhibit 150: Eurofins Scientific SE - Business segments
• Exhibit 151: Eurofins Scientific SE - Key news
• Exhibit 152: Eurofins Scientific SE - Key offerings
• Exhibit 153: Eurofins Scientific SE - Segment focus

• 12.12 F. Hoffmann La Roche Ltd. 
• Exhibit 154: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 155: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 156: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 157: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 158: F. Hoffmann La Roche Ltd. - Segment focus

• 12.13 Meso Scale Diagnostics LLC 
• Exhibit 159: Meso Scale Diagnostics LLC - Overview
• Exhibit 160: Meso Scale Diagnostics LLC - Product / Service
• Exhibit 161: Meso Scale Diagnostics LLC - Key offerings

• 12.14 Nexus Dx Inc. 
• Exhibit 162: Nexus Dx Inc. - Overview
• Exhibit 163: Nexus Dx Inc. - Product / Service
• Exhibit 164: Nexus Dx Inc. - Key offerings

• 12.15 QIAGEN NV 
• Exhibit 165: QIAGEN NV - Overview
• Exhibit 166: QIAGEN NV - Product / Service
• Exhibit 167: QIAGEN NV - Key news
• Exhibit 168: QIAGEN NV - Key offerings

• 12.16 Siemens AG 
• Exhibit 169: Siemens AG - Overview
• Exhibit 170: Siemens AG - Business segments
• Exhibit 171: Siemens AG - Key news
• Exhibit 172: Siemens AG - Key offerings
• Exhibit 173: Siemens AG - Segment focus

• 12.17 Thermo Fisher Scientific Inc. 
• Exhibit 174: Thermo Fisher Scientific Inc. - Overview
• Exhibit 175: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 176: Thermo Fisher Scientific Inc. - Key news
• Exhibit 177: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 178: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report 

• 13.2 Inclusions and exclusions checklist
• Exhibit 179: Inclusions checklist
• Exhibit 180: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 181: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 182: Research methodology
• Exhibit 183: Validation techniques employed for market sizing
• Exhibit 184: Information sources

• 13.5 List of abbreviations 
• Exhibit 185: List of abbreviations 

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio